Groupe La Francaise Minerva Neurosciences, Inc. Transaction History
Groupe La Francaise
- $7.39 Trillion
- Q3 2025
A detailed history of Groupe La Francaise transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Groupe La Francaise holds 337 shares of NERV stock, worth $1,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
337Holding current value
$1,381% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NERV
# of Institutions
22Shares Held
1.98MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA1.35MShares$5.54 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA252KShares$1.03 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny117KShares$477,6490.0% of portfolio
-
Geode Capital Management, LLC Boston, MA75.6KShares$310,0620.0% of portfolio
-
Black Rock Inc. New York, NY72.7KShares$297,9420.0% of portfolio
About Minerva Neurosciences, Inc.
- Ticker NERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,340,190
- Market Cap $21.9M
- Description
- Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...